These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 15218971)
1. EBV-positive Burkitt lymphoma as a late-onset posttransplantion lymphoproliferative disorder after allogeneic stem cell transplantation. Sekiguchi N; Nishimoto J; Tanosaki R; Kubota N; Yokota Y; Kobayashi Y; Watanabe T; Kami M; Takaue Y; Matsuno Y; Tobinai K Int J Hematol; 2004 May; 79(4):387-9. PubMed ID: 15218971 [TBL] [Abstract][Full Text] [Related]
2. Examining the origin of posttransplant lymphoproliferative disorder in a patient after a second allogeneic hematopoeitic stem cell transplantation for relapsed BCR-ABL positive acute lymphoblastic leukemia. Ruf S; Moser O; Wössmann W; Kreyenberg H; Wagner HJ J Pediatr Hematol Oncol; 2011 Jan; 33(1):50-4. PubMed ID: 21178708 [TBL] [Abstract][Full Text] [Related]
3. Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies. Gao XN; Lin J; Wang LJ; Li F; Li HH; Wang SH; Huang WR; Gao CJ; Yu L; Liu DH Ann Hematol; 2019 Sep; 98(9):2163-2177. PubMed ID: 31243569 [TBL] [Abstract][Full Text] [Related]
4. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases]. Chen DB; Wang Y; Song QJ; Shen DH Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829 [TBL] [Abstract][Full Text] [Related]
5. Development of a biologically distinct EBV-related lymphoproliferative disorder following autologous bone marrow transplantation for an EBV-negative post-renal allograft Burkitt's lymphoma. Lohrisch CA; Nevill TJ; Barnett MJ; Hogge DE; Connors JM; Keown PA; Gascoyne RD Leuk Lymphoma; 2000 Sep; 39(1-2):195-201. PubMed ID: 10975399 [TBL] [Abstract][Full Text] [Related]
6. Burkitt s lymphoma variant of post-transplant lymphoproliferative disease (PTLD). Pasquale MA; Weppler D; Smith J; Icardi M; Amador A; Gonzalez M; Kato T; Tzakis A; Ruiz P Pathol Oncol Res; 2002; 8(2):105-8. PubMed ID: 12172573 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation. Liu QF; Fan ZP; Luo XD; Sun J; Zhang Y; Ding YQ Transpl Infect Dis; 2010 Aug; 12(4):284-91. PubMed ID: 20345506 [TBL] [Abstract][Full Text] [Related]
8. [Epstein-Barr virus-associated post-transplant lymphoproliferative disorder diagnosed by the episode of intestinal perforation following allogeneic hematopoietic stem cell transplantation]. Aimoto M; Yamane T; Inoue A; Momose D; Moriguchi-Aimoto R; Wada-Inoue E; Okamoto S; Koh H; Nakane T; Takeoka Y; Akahori-Nakamae M; Nishiki-Kosaka S; Terada Y; Nakamae H; Koh KR; Nakao T; Ohsawa M; Hino M Rinsho Ketsueki; 2010 Dec; 51(12):1775-80. PubMed ID: 21258188 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation. Meyer SC; Medinger M; Halter JP; Baldomero H; Hirsch HH; Tzankov A; Dirnhofer S; Passweg JR; Tichelli A Hematology; 2014 Jul; 19(5):280-5. PubMed ID: 24074746 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan. Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884 [TBL] [Abstract][Full Text] [Related]
11. Post‑transplant lymphoproliferative disorder in hematopoietic stem cell transplant patients: A single center retrospective study between 2005 and 2012. Marinho-Dias J; Lobo J; Henrique R; Baldaque I; Pinho-Vaz C; Regadas L; Branca R; Campilho F; Campos A; Medeiros R; Sousa H Mol Med Rep; 2018 Nov; 18(5):4650-4656. PubMed ID: 30221663 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation. Nozzoli C; Bartolozzi B; Guidi S; Orsi A; Vannucchi AM; Leoni F; Bosi A Leuk Lymphoma; 2006 Jan; 47(1):167-9. PubMed ID: 16321845 [TBL] [Abstract][Full Text] [Related]
17. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction. Kinch A; Oberg G; Arvidson J; Falk KI; Linde A; Pauksens K Scand J Infect Dis; 2007; 39(3):235-44. PubMed ID: 17366054 [TBL] [Abstract][Full Text] [Related]
18. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation. Sundin M; Le Blanc K; Ringdén O; Barkholt L; Omazic B; Lergin C; Levitsky V; Remberger M Haematologica; 2006 Aug; 91(8):1059-67. PubMed ID: 16885046 [TBL] [Abstract][Full Text] [Related]
19. Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder. Picarsic J; Jaffe R; Mazariegos G; Webber SA; Ellis D; Green MD; Reyes-Múgica M Cancer; 2011 Oct; 117(19):4540-50. PubMed ID: 21446044 [TBL] [Abstract][Full Text] [Related]